Regulatory Sourcebook eBook
Read the article:
Collecting Industry’s Thoughts on FDA FARS Report
Read the ebook:
BioPharm International’s Regulatory Sourcebook eBook
Industry representatives sound off on FDA’s FARS report, released in January this year.
gorynvd/Stock.adobe.com
FDA’s January 2021 release of its Focus Areas of Regulatory Science (FARS) report outlines topics that need continued targeted investment to advance regulatory science research that can facilitate the development of innovative products. The report also outlines the agency’s needs for data provision and methodology clarification to inform its regulatory decision-making process in the hopes that this will improve guidance for sponsors. Representatives from Bio-Process Systems Alliance and BioPhorum shared their thoughts on the report and provided feedback from an industry perspective.
Read this article in BioPharm International’s October 2021 Regulatory Sourcebook eBook.
Read the article:
Collecting Industry’s Thoughts on FDA FARS Report
Read the ebook:
BioPharm International’s Regulatory Sourcebook eBook
Feliza Mirasol is the science editor for BioPharm International.
BioPharm International
eBook: Regulatory Sourcebook, October 2021
October 2021
Pages: 4–5
When referring to this article, please cite it as F. Mirasol, “Collecting Industry’s Thoughts on FDA FARS Report," BioPharm International Regulatory Sourcebook eBook (October 2021).
VERAXA and Voyager to Create Combined Business for Advancing Pipeline of Next-Gen Cancer Therapies
April 23rd 2025The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company that will focus on developing a pipeline of next-generation cancer therapies.
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.